Announcements Trials
Browse Landscape

Phase

Phase 1 4Phase 2 1

Status

Completed 4Terminated 1

Sponsor Class

OTHER 28NETWORK 18NIH 5

Study Type

Interventional 5

Sponsor

Cancer Type

Lymphoid 17Other hematologic neoplasm 14Sarcoma 5CNS 5Breast 5Gynecologic 3Myeloid 2Thoracic 1Plasma cell 1Head & Neck 1Genitourinary 1Dermatologic 1Classical hematology 1

Conditions

Neuroblastoma 3Squamous Cell Carcinoma of Head and Neck 1Sarcoma, Ewing 1Salivary Gland Neoplasms 1Rhabdomyosarcoma 1Optic Nerve Glioma 1Oligodendroglioma 1Medulloblastoma 1Familial ependymoma 1Esthesioneuroblastoma, Olfactory 1Choroid Plexus Neoplasms 1Astrocytoma 1

Interventions

Radiotherapy 63Temozolomide 59Magnetic Resonance Spectroscopy 46Carboplatin 40Cyclophosphamide 39Vincristine 35Specimen Handling 28Etoposide 26Cisplatin 26Radiation 22Chemotherapy, Adjuvant 22Filgrastim 20Bevacizumab 20Doxorubicin 18Peripheral Blood Stem Cell Transplantation 17Biopsy 17Vorinostat 16Surgical Procedures, Operative 14Melphalan 13Immunoglobulin G 13Disulfides 13Radiotherapy, Conformal 12Isotretinoin 12Erlotinib Hydrochloride 12X-Rays 11Nivolumab 11Irinotecan 11Carmustine 11aldesleukin 10Topotecan 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
NIH × Granulocyte Colony-Stimulating Factor × CNS × Clear all
NCT00052780 2013-09-30

Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain Tumors

National Cancer Institute (NCI)

Phase 1 Completed
72 enrolled
CNS

Familial ependymoma, Astrocytoma, Medulloblastoma, Oligodendroglioma, Choroid Plexus Neoplasms, Optic Nerve Glioma

NCT00075634 2013-09-30

Decitabine, Doxorubicin, and Cyclophosphamide in Treating Children With Relapsed or Refractory Solid Tumors or Neuroblastoma

National Cancer Institute (NCI)

Phase 1 Completed
21 enrolled
CNS

Neuroblastoma

NCT00053950 2013-04-09

Pyrazoloacridine and Stem Cell or Bone Marrow Transplantation in Treating Young Patients With High-Risk Neuroblastoma

National Cancer Institute (NCI)

Phase 1 Terminated
42 enrolled
CNS

Neuroblastoma

NCT00023959 2013-02-07

Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer

National Cancer Institute (NCI)

Phase 1 Completed
39 enrolled
CNSHead & Neck

Squamous Cell Carcinoma of Head and Neck, Salivary Gland Neoplasms, Esthesioneuroblastoma, Olfactory

NCT00001335 2008-03-04

New Therapeutic Strategies for Patients With Ewing's Sarcoma Family of Tumors, High Risk Rhabdomyosarcoma, and Neuroblastoma

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
90 enrolled
CNSSarcoma

Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon âš¡